The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 527.80
Bid: 526.40
Ask: 527.20
Change: 9.60 (1.85%)
Spread: 0.80 (0.152%)
Open: 522.60
High: 527.80
Low: 511.40
Prev. Close: 518.20
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Ordinary General Meeting- replace

14 Aug 2023 09:08

RNS Number : 2166J
B&M European Value Retail S.A.
14 August 2023
 

FORMATTING AMENDMENT

 

The 'Notice of Ordinary General Meeting' announcement released on 14 August 2023 at 7am under RNS No 1258J has been reformatted to the correct hyperlink.

 

All material details remain unchanged.

 

The full text is shown below.

 

 

 

 

 

 

14 August 2023

 

 

B&M European Value Retail S.A.

68-70, Boulevard de la Pétrusse

L-2320 Luxembourg

(the "Company")

 

 Notice of Ordinary General Meeting

 

B&M European Value Retail S.A. (the "Company"), the UK's leading general merchandise value retailer, announces that it has posted to shareholders today Notice of an Ordinary General Meeting of the Company.

 

The Ordinary General Meeting will be held on Friday 22 September 2023 at Sofitel Luxembourg Europe, 4, rue du Fort Niedergrünewald, L-2226 Luxembourg, commencing at 08:00 am (CET).

 

The purpose of the Ordinary General Meeting is to propose the appointment of Hounaïda Lasry as Director of the Company.

 

The Notice of the Ordinary General Meeting, is available on the Company's website at https://www.bandmretail.com/investors/company-meetings/ogm

 

 

A summary form of the Notice of the Ordinary General Meeting is set out in Appendix 1 to this announcement.

 

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Alejandro Russo, Chief Executive Officer

Dave McCarthy, Head of Investor Relations

Investor.relations@bandmretail.com

 

 

 

APPENDIX 1

 

B&M European Value Retail S.A.

Société Anonyme

Registered office: 68-70, Boulevard de la Pétrusse, L-2320 Luxembourg

Grand-Duchy of Luxembourg

R.C.S. Luxembourg: B 187275

 

Notice of the Ordinary General Meeting of B&M European Value Retail S.A. to be held at 8:00 am (CET) on Friday 22 September 2023 at the SOFITEL LUXEMBOURG EUROPE, 4, rue du Fort Niedergrünewald, L-2226 Luxembourg, Grand-Duchy of Luxembourg.

 

AGENDA

1. To appoint Hounaïda Lasry as a Director of the Company with immediate effect until the Annual General Meeting resolving on the financial statements for the financial year ended 31 March 2024.

 

Explanation of Business to be considered at the Ordinary Generla Meeting.

 

Resolution: Appointment of a Non-Executive Director

Presently and following the retirement of Carolyn Bradley, the Board of Directors of B&M European Value Retail S.A. (the "Board") has seven members, comprising the Non-Executive Chairman, two Executive Directors and four Independent Non-Executive Directors.

 

Following a search undertaken by Audeliss on behalf of the Nomination Committee of the Company and a series of interviews, the Nomination Committee has recommended to the Board that Hounaïda Lasry be appointed as a Non-Executive Director of the Company. The Board approved that recommendation and unanimously resolved to propose to the shareholders the appointment of Hounaïda Lasry with immediate effect.

 

Hounaïda is currently a Non-Executive Director at Britvic plc.

 

Hounaïda had almost 30 years' experience at Procter & Gamble across various sectors (Skin & Personal Care, Pet Food, Sanitary Pads, Diapers and Detergents) and geographies (Europe, Middle East, Africa and Asia). In her final role, she had responsibility for a portfolio of 5 brands across Europe, backed by strong operational experience in leading business turnarounds and organization transformation. From 2016 to 2021, Hounaïda was a Non-Executive Director on the Advisory Board of the Geneva School of Economics and Management.

 

Notes

 

Quorum and voting

The quorum for the Meeting is at least one shareholder present in person or represented by proxy. Each holder of ordinary shares has one vote in respect of each ordinary share held, save when voting rights are suspended. The resolution will be passed if approved by a simple majority of the votes cast, regardless of the proportion of the issued share capital represented by shareholders at the Meeting.

 

Total voting rights

As at 11 August 2023 (being the last business day prior to the publication of this notice) the Company's issued ordinary share capital consists of 1,001,853,735 (one billion one million eight hundred and fifty-three thousand seven hundred and thirty-five) ordinary shares, carrying one vote each. The Company holds no treasury shares, but voting rights attached to 13,842 (thirteen thousand eight hundred and forty-two) shares in aggregate are being suspended and the total number of voting rights in the Company as at 11 August 2023 is therefore of 1,001,839,893 (one billion one million eight hundred and thirty-nine thousand eight hundred and ninety-three).

 

Poll

All items in the Notice of the Meeting will be decided by a poll of shareholders.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGVZLBFXVLBBBQ
Date   Source Headline
24th Apr 20249:00 amRNSNotice of Ordinary General Meeting
16th Apr 20247:00 amRNSFY24 Post Close Trading Statement
4th Apr 202410:00 amRNSNotice of FY24 Post Close Trading Statement
22nd Mar 20249:00 amRNSBoard Appointment
8th Feb 20249:00 amRNSConfirmation of timing of FY24 Preliminary Results
1st Feb 20241:00 pmRNSMajor Shareholding in Company TR-1
30th Jan 20246:23 pmRNSHolding(s) in Company
24th Jan 202410:00 amRNSPDMR Purchase of Shares
23rd Jan 202412:00 pmRNSB&M Plans Chairman Succession
18th Jan 20242:46 pmRNSNotification of Major Shareholding
15th Jan 20242:20 pmRNSBlock listing Interim Review
9th Jan 20247:00 amRNSGolden Quarter - strong profitable growth
22nd Dec 202312:00 pmRNSCorrection: PDMR announcement
22nd Dec 20238:30 amRNSPost Stabilisation Notice
19th Dec 20239:04 amRNSPCA Notification
15th Dec 20239:00 amRNSNotification of major holdings
13th Dec 202312:10 pmRNSAnnouncement further to recent placing by SSA
30th Nov 20235:41 pmRNSChange of Registered Office
30th Nov 20234:01 pmRNSTotal Voting Rights
28th Nov 20239:22 amRNSDirector/PDMR Shareholding
27th Nov 20235:13 pmRNSNotice of FY24 Third Quarter Trading Statement
24th Nov 202310:35 amRNSPDMR Notification
21st Nov 202311:32 amRNSFinal Results of Tender Offer 3.625% Senior Notes
15th Nov 202310:11 amRNSTender Offer Indicative Maximum Acceptance Amount
14th Nov 20235:52 pmRNSPricing of £250 Million Senior Secured Notes
13th Nov 20232:28 pmRNSPre Stabilisation Notice
13th Nov 20239:39 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:30 amRNSTender Offer
13th Nov 20239:27 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:07 amRNS£250 Million Senior Secured Notes Offering
9th Nov 20237:00 amRNSFY24 Interim Results
3rd Oct 20237:25 amRNSTotal Voting Rights
22nd Sep 202311:33 amRNSDirector Appointment and Results of OGM
19th Sep 20238:50 amRNSTiming of announcement of Half Year Results
7th Sep 20232:19 pmRNSNotification of major holdings
7th Sep 20231:31 pmRNSDirector/PDMR Shareholding
5th Sep 20239:48 amRNSAcquisition of Assets from Wilko Ltd (in admin)
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Aug 20239:08 amRNSNotice of Ordinary General Meeting- replace
14th Aug 20237:00 amRNSNotice of Ordinary General Meeting
9th Aug 20234:02 pmRNSGrant of share options to PDMR
2nd Aug 20239:21 amRNSGrant of options to senior managers
2nd Aug 20239:18 amRNSGrant of options to Directors
28th Jul 20237:00 amRNSGroup Trading Director Retention Agreement
27th Jul 20231:42 pmRNSTR-1 Correction Announcement
26th Jul 20234:15 pmRNSTR-1 Notification of major holdings
26th Jul 20233:33 pmRNSBoard change
26th Jul 20238:45 amRNSEGM Voting results announcement
26th Jul 20238:15 amRNSAGM 2023 Voting results announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.